Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S20 pseudogene 35 (RPS20P35) is a human processed pseudogene corresponding to the functional ribosomal protein S20 (RPS20) gene[4][6]. Unlike the functional gene, RPS20P35 does not encode a protein and is classified as a non-coding genetic element. It is primarily of genomic or evolutionary interest and does not participate directly in protein synthesis or cellular signaling pathways. Pseudogenes like RPS20P35 are remnants of gene duplication or retrotransposition events and are dispersed throughout the genome. Although the functional RPS20 gene plays an integral role in ribosome assembly and function, RPS20P35 does not produce any active protein and is not a receptor, enzyme, or classical drug target[1][4][6][11]. In summary, ribosomal protein S20 pseudogene 35 is not a druggable or therapeutically relevant gene and serves no known direct biological or disease-related function. Its presence is notable only in genomic annotation and evolutionary studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S20 pseudogene 35 (RPS20P35).